Francesca Benedetti1, Sabrina Curreli2, Robert C Gallo2, Davide Zella3. 1. Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. 2. Institute of Human Virology and Global Virus Network Center, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. 3. Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. dzella@ihv.umaryland.edu.
Abstract
BACKGROUND: Studies of molecular mechanisms underlying tumor cell signaling highlighted a critical role for kinases in carcinogenesis and cancer progression. To this regard, protein kinases regulates a number of critical cellular pathways by adding phosphate groups to specific substrates. For this reason, their involvement in the complex interactions between the human microbiota and cancer cells to determine therapy and tumor progression outcome is becoming increasingly relevant. Mycoplasmas are components of the normal human microbiota, and several species have also been associated to human diseases, including certain cancers. It is also important to note that Mycoplasmas and their proteins are a component of the common tumor microenvironment. In addition, several epidemiological, in vivo and in vitro studies indicate a close involvement of Mycoplasmas in cellular transformation and cancer progression. METHODS: In this study, we investigate the effect of exogenous Mycoplasma DnaK on kinases activity by treating in vitro four different eukaryotic cancer cell lines, namely lung and prostate cancer, colon adenocarcinoma, and neuroblastoma. Phosphorylation of kinases and specific substrates was measured at 20 and 60 min. RESULTS: Kinome analysis of our data indicates that Mycoplasma DnaK promotes the dysregulation of the activity of specific kinases and their substrates, with a known involvement in carcinogenesis and cancer progression. CONCLUSIONS: Given the similarity in structure and amino acid composition of this protein with other bacterial DnaKs we provide a novel mechanism whereby components of the human microbiota and present in the tumor microenvironment are able to deregulate phosphorylation events occurring during carcinogenesis and cancer progression.
BACKGROUND: Studies of molecular mechanisms underlying tumor cell signaling highlighted a critical role for kinases in carcinogenesis and cancer progression. To this regard, protein kinases regulates a number of critical cellular pathways by adding phosphate groups to specific substrates. For this reason, their involvement in the complex interactions between the human microbiota and cancer cells to determine therapy and tumor progression outcome is becoming increasingly relevant. Mycoplasmas are components of the normal human microbiota, and several species have also been associated to human diseases, including certain cancers. It is also important to note that Mycoplasmas and their proteins are a component of the common tumor microenvironment. In addition, several epidemiological, in vivo and in vitro studies indicate a close involvement of Mycoplasmas in cellular transformation and cancer progression. METHODS: In this study, we investigate the effect of exogenous Mycoplasma DnaK on kinases activity by treating in vitro four different eukaryotic cancer cell lines, namely lung and prostate cancer, colon adenocarcinoma, and neuroblastoma. Phosphorylation of kinases and specific substrates was measured at 20 and 60 min. RESULTS: Kinome analysis of our data indicates that Mycoplasma DnaK promotes the dysregulation of the activity of specific kinases and their substrates, with a known involvement in carcinogenesis and cancer progression. CONCLUSIONS: Given the similarity in structure and amino acid composition of this protein with other bacterial DnaKs we provide a novel mechanism whereby components of the human microbiota and present in the tumor microenvironment are able to deregulate phosphorylation events occurring during carcinogenesis and cancer progression.
Authors: Hong Seo Choi; Hyun Min Lee; Won-Tae Kim; Min Kyu Kim; Hee Jin Chang; Hye Ran Lee; Jae-Won Joh; Dae Shick Kim; Chun Jeih Ryu Journal: Biochem Biophys Res Commun Date: 2014-03-15 Impact factor: 3.575
Authors: Emmani B M Nascimento; Mariann Fodor; Gerard C M van der Zon; Ingrid M Jazet; A Edo Meinders; Peter J Voshol; Ronald Vlasblom; Bart Baan; Jürgen Eckel; J Antonie Maassen; Michaela Diamant; D Margriet Ouwens Journal: Diabetes Date: 2006-12 Impact factor: 9.461
Authors: R R Reddel; S E Salghetti; J C Willey; Y Ohnuki; Y Ke; B I Gerwin; J F Lechner; C C Harris Journal: Cancer Res Date: 1993-03-01 Impact factor: 12.701
Authors: C Campanella; F Bucchieri; N M Ardizzone; A Marino Gammazza; A Montalbano; A Ribbene; V Di Felice; M Bellafiore; S David; F Rappa; M Marasà; G Peri; F Farina; A M Czarnecka; E Conway de Macario; A J L Macario; G Zummo; F Cappello Journal: Eur J Histochem Date: 2008 Oct-Dec Impact factor: 3.188